title: Response to teszler.
authors.forename: Hanneke M
authors.initials: HM
authors.lastname: van Santen
authors.forename: Godelieve A M
authors.initials: GA
authors.lastname: Tytgat
authors.forename: Marianne D
authors.initials: MD
authors.lastname: van de Wetering
authors.forename: Berthe L F
authors.initials: BL
authors.lastname: van Eck-Smit
authors.forename: Saskia M J
authors.initials: SM
authors.lastname: Hopman
authors.forename: Alida F
authors.initials: AF
authors.lastname: van der Steeg
authors.forename: Els J M
authors.initials: EJ
authors.lastname: Nieveen van Dijkum
authors.forename: A S Paul
authors.initials: AS
authors.lastname: van Trotsenburg
mesh_terms: D019797:3-Iodobenzylguanidine / Q000009:adverse effects* / Q000627:therapeutic use*; D000310:Adrenal Gland Neoplasms / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D008297:Male; D009447:Neuroblastoma / Q000532:radiotherapy*; D013899:Thoracic Neoplasms / Q000532:radiotherapy*; D013964:Thyroid Neoplasms / Q000000981:diagnostic imaging* / Q000209:etiology*; D014463:Ultrasonography
chemical_list: D019797:3-Iodobenzylguanidine